High Risk

28 clinical trials · Condition

Record	Firm	Date
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer (NCT05430737)	West China Hospital	2022-06-30
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure Patients (NCT05103267)	Federico II University	2022-06-06
Imaging vs. no Testing in Asymptomatic High-risk Diabetic Patients (NCT04388280)	Clinical Centre of Serbia	2021-01-28
Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable (NCT04730232)	Tianjin Medical University Second Hospital	2020-12-27
68 Ga-PSMA for High Risk Prostate Cancer (NCT04614363)	The Methodist Hospital Research Institute	2020-10-13
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman (NCT04548102)	Cairo University	2019-09-30
Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy (NCT07074951)	St. Petersburg State Pavlov Medical University	2013-03-10
Enhancing Father's Ability to Support Their Preschool Child (NCT01395238)	Queens College, The City University of New York	2010-09-01
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" (NCT01030861)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2010-08-01
A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients (NCT01788137)	Sun Yat-sen University	2008-01-01
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission (NCT04298619)	Federico II University	2001-06-01
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) (NCT00590785)	National Cancer Institute (NCI)	1996-08-13

Track High Risk automatically

Every clearance here is in the API, with alerts when new ones post.